Seres Therapeutics, Inc.MCRBNASDAQ
Loading
Cash & Equivalents Over TimeContracting
Percentile Rank31
3Y CAGR-34.5%
5Y CAGR-17.0%
Year-over-Year Change
Cash on hand plus short-term liquid investments
3Y CAGR
-34.5%/yr
vs +17.4%/yr prior
5Y CAGR
-17.0%/yr
Recent deceleration
Acceleration
-51.9pp
Decelerating
Percentile
P31
Within normal range
vs 5Y Ago
0.4x
Contraction
Streak
1 yr
Consecutive growthContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $45.77M | +48.6% |
| 2024 | $30.79M | -75.9% |
| 2023 | $127.97M | -21.5% |
| 2022 | $163.03M | -9.4% |
| 2021 | $180.00M | +55.1% |
| 2020 | $116.05M | +78.2% |
| 2019 | $65.13M | -24.1% |
| 2018 | $85.82M | +137.8% |
| 2017 | $36.09M | -33.8% |
| 2016 | $54.54M | - |